Selected article for: "administration route timing duration and route timing"
Author: Rocio Bravo Jeria; Maria X Rojas Reyes; Juan V Franco; Maria P Acuna; Luz A Torres Lopez; Gabriel rada Rada
Title: Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol
  • Document date: 2020_4_8
    • ID: fckn8ld4_46
    Snippet: Using standardised forms, two reviewers will extract data independently from each included study. We will collect the following information: study design, setting, participant characteristics (including disease severity and age) and study eligibility criteria; details about the administered intervention and comparison, including dose and therapeutic scheme, duration, timing (i.e. time after diagnosis) and route of administration; the outcomes ass.....
    Document: Using standardised forms, two reviewers will extract data independently from each included study. We will collect the following information: study design, setting, participant characteristics (including disease severity and age) and study eligibility criteria; details about the administered intervention and comparison, including dose and therapeutic scheme, duration, timing (i.e. time after diagnosis) and route of administration; the outcomes assessed and the time they were measured; the source of funding of the study and the conflicts of interest disclosed by the investigators; the risk of bias assessment for each individual study. 7 . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • administer intervention and individual study: 1
    • administration route and age disease severity: 1
    • administration route and bias assessment: 1
    • administration route and diagnosis time: 1
    • administration route and diagnosis time timing: 1
    • administration route and disease severity: 1, 2, 3
    • administration route and include study: 1
    • administration route and individual study: 1
    • administration route and individual study bias assessment: 1
    • administration route and individual study bias assessment risk: 1
    • administration route diagnosis time timing and age disease severity: 1
    • administration route diagnosis time timing and bias assessment: 1
    • administration route diagnosis time timing and diagnosis time: 1
    • administration route diagnosis time timing and diagnosis time timing: 1
    • administration route diagnosis time timing and disease severity: 1
    • administration route diagnosis time timing and individual study: 1
    • administration route diagnosis time timing and individual study bias assessment: 1
    • administration route diagnosis time timing and individual study bias assessment risk: 1
    • administration route diagnosis time timing duration and individual study bias assessment risk: 1